Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplemental Table 2 from LNS8801: An Enantiomerically Pure Agonist of the G Protein–Coupled Estrogen Receptor Suitable for Clinical Development
  1. Home
  2. Publications
  3. Supplemental Table 2 from LNS8801: An Enantiomerically Pure Agonist of the G Protein–Coupled Estrogen Receptor Suitable for Clinical Development

Supplemental Table 2 from LNS8801: An Enantiomerically Pure Agonist of the G Protein–Coupled Estrogen Receptor Suitable for Clinical Development

Authors:
  • CNChristopher A. Natale
    Christopher A. Natale
  • SMSophia Mercado
    Sophia Mercado
  • RZRichard Zhuang
    Richard Zhuang
  • CACristina Aguirre-Portolés
    Cristina Aguirre-Portolés
  • IOIsrael Olayide
    Israel Olayide
  • CAChristopher K. Arnatt
    Christopher K. Arnatt
  • JSJohn T. Seykora
    John T. Seykora
  • TGTina K. Garyantes
    Tina K. Garyantes
  • WLWayne Luke
    Wayne Luke
  • TRTodd W. Ridky
    Todd W. Ridky

Open Access
Publisher website
Google Scholar
  • 13 May 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2767-9764.29051147
Abstract
Log-rank (Mantel-Cox) all comparisions of data in Figure 2 and 4.
Keywords
  • DRUG TARGETS
  • ONCOGENES
  • SMALL MOLECULE AGENTS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.